The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Open accessAbstract
Antibodies are important tools for experimental research and medical applications. Most antibodies are composed of two heavy and two light chains. Both chains contribute to the antigen-binding site which is usually flat or concave. In addition to these conventional antibodies, llamas, other camelids, and sharks also produce antibodies composed only of heavy chains. The antigen-binding site of these unusual heavy chain antibodies (hcAbs) is formed only by a single domain, designated VHH in camelid hcAbs and VNAR in shark hcAbs. VHH and VNAR are easily produced as recombinant proteins, designated single domain antibodies (sdAbs) or nanobodies. The CDR3 region of these sdAbs possesses the extraordinary capacity to form long fingerlike extensions that can extend into cavities on antigens, e.g., the active site crevice of enzymes. Other advantageous features of nanobodies include their small size, high solubility, thermal stability, refolding capacity, and good tissue penetration in vivo. Here we review the results of several recent proof-of-principle studies that open the exciting perspective of using sdAbs for modulating immune functions and for targeting toxins and microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naturally occurring antibodies devoid of light chains
Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hammers, C., Songa, E. B., Bendahman, N., & Hammers, R. (1993) · Nature · doi:10.1038/363446a0 · Cited by 3,241
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Selecting and screening recombinant antibody libraries
Hoogenboom, H. R. (2005) · Nature Biotechnology · doi:10.1038/nbt1126 · Cited by 973
Properties, production, and applications of camelid single-domain antibody fragments
Harmsen, M. M., & De Haard, H. J. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1142-2 · Cited by 809 · cited 1×
“sdAbs generally display high solubility and stability and can also be readily produced in yeast, plant, and mammalian cells [8].”
BackgroundGreenberg, A. S., Avila, D., Hughes, M., Hughes, A., McKinney, E. C., & Flajnik, M. F. (1995) · Nature · doi:10.1038/374168a0 · Cited by 775
Targeting and tracing antigens in live cells with fluorescent nanobodies
Rothbauer, U., Zolghadr, K., Tillib, S., Nowak, D., Schermelleh, L., Gahl, A., Backmann, N., Conrath, K., Muyldermans, S., Cardoso, M. C., et al. (2006) · Nature Methods · doi:10.1038/nmeth953 · Cited by 710
Nucleotide receptors: an emerging family of regulatory molecules in blood cells
Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G., & Baricordi, O. R. (2001) · Blood · doi:10.1182/blood.v97.3.587 · Cited by 703
A Versatile Nanotrap for Biochemical and Functional Studies with Fluorescent Fusion Proteins
Rothbauer, U., Zolghadr, K., Muyldermans, S., Schepers, A., Cardoso, M. C., & Leonhardt, H. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700342-mcp200 · Cited by 677
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
De Genst, E., Silence, K., Decanniere, K., Conrath, K., Loris, R., Kinne, J., Muyldermans, S., & Wyns, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505379103 · Cited by 676
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Single‐domain antibody fragments with high conformational stability
Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L. G. J., Muyldermans, S., Wyns, L., & Matagne, A. (2002) · Protein Science · doi:10.1110/ps.34602 · Cited by 638
Anti-TNF-α therapies: the next generation
Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1175 · Cited by 576
Vincke, C., Loris, R., Saerens, D., Martinez-Rodriguez, S., Muyldermans, S., & Conrath, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806889200 · Cited by 572
Single domain camel antibodies: current status
Muyldermans, S. (2001) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(01)00021-6 · Cited by 552
Therapeutic antibodies for human diseases at the dawn of the twenty-first century
Brekke, O. H., & Sandlie, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd984 · Cited by 550
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme
Desmyter, A., Transue, T. R., Ghahroudi, M. A., Dao Thi, M.-H., Poortmans, F., Hamers, R., Muyldermans, S., & Wyns, L. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0996-803 · Cited by 522
Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning
Schenk, D. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn938 · Cited by 436
Efficient Cancer Therapy with a Nanobody-Based Conjugate
Cortez-Retamozo, V., Backmann, N., Senter, P. D., Wernery, U., De Baetselier, P., Muyldermans, S., & Revets, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3935 · Cited by 382
Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
Goldenberg, D. M., Sharkey, R. M., Paganelli, G., Barbet, J., & Chatal, J.-F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8471 · Cited by 351
β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae
Conrath, K. E., Lauwereys, M., Galleni, M., Matagne, A., Frère, J.-M., Kinne, J., Wyns, L., & Muyldermans, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2807-2812.2001 · Cited by 347
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Roovers, R. C., Laeremans, T., Huang, L., De Taeye, S., Verkleij, A. J., Revets, H., de Haard, H. J., & van Bergen en Henegouwen, P. M. P. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0180-4 · Cited by 346
Seman, M., Adriouch, S., Scheuplein, F., Krebs, C., Freese, D., Glowacki, G., Deterre, P., Haag, F., & Koch-Nolte, F. (2003) · Immunity · doi:10.1016/s1074-7613(03)00266-8 · Cited by 335
Self-citationTijink, B. M., Laeremans, T., Budde, M., Walsum, M. S.-V., Dreier, T., de Haard, H. J., Leemans, C. R., & van Dongen, G. A. M. S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2384 · Cited by 305
Coppieters, K., Dreier, T., Silence, K., Haard, H. D., Lauwereys, M., Casteels, P., Beirnaert, E., Jonckheere, H., Wiele, C. V. D., Staelens, L., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21827 · Cited by 303
Els Conrath, K., Lauwereys, M., Wyns, L., & Muyldermans, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007734200 · Cited by 300
Crystal Structure of a Shark Single-Domain Antibody V Region in Complex with Lysozyme
Stanfield, R. L., Dooley, H., Flajnik, M. F., & Wilson, I. A. (2004) · Science · doi:10.1126/science.1101148 · Cited by 297
NEW EMBO MEMBER'S REVIEW: Functional aspects of protein mono-ADP-ribosylation
Corda, D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg209 · Cited by 294
Length distribution of CDRH3 in antibodies
Wu, T. T., Johnson, G., & Kabat, E. A. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340160102 · Cited by 284
Cell-surface enzymes in control of leukocyte trafficking
Salmi, M., & Jalkanen, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1705 · Cited by 281
Efficient Targeting of Conserved Cryptic Epitopes of Infectious Agents by Single Domain Antibodies
Stijlemans, B., Conrath, K., Cortez-Retamozo, V., Van Xong, H., Wyns, L., Senter, P., Revets, H., De Baetselier, P., Muyldermans, S., & Magez, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307341200 · Cited by 276
Efficient tumor targeting by single‐domain antibody fragments of camels
Cortez‐Retamozo, V., Lauwereys, M., Hassanzadeh Gh., G., Gobert, M., Conrath, K., Muyldermans, S., De Baetselier, P., & Revets, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10212 · Cited by 260
Muruganandam, A., Tanha, J., Narang, S., & Stanimirovic, D. (2002) · The FASEB Journal · doi:10.1096/fj.01-0343fje · Cited by 260
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme
Dumoulin, M., Last, A. M., Desmyter, A., Decanniere, K., Canet, D., Larsson, G., Spencer, A., Archer, D. B., Sasse, J., Muyldermans, S., et al. (2003) · Nature · doi:10.1038/nature01870 · Cited by 246
Increasing the serum persistence of an IgG fragment by random mutagenesis
Ghetie, V., Popov, S., Borvak, J., Radu, C., Matesoi, D., Medesan, C., Ober, R. J., & Ward, E. S. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-637 · Cited by 241
Gainkam, L. O. T., Huang, L., Caveliers, V., Keyaerts, M., Hernot, S., Vaneycken, I., Vanhove, C., Revets, H., De Baetselier, P., & Lahoutte, T. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048538 · Cited by 222
Habicht, G., Haupt, C., Friedrich, R. P., Hortschansky, P., Sachse, C., Meinhardt, J., Wieligmann, K., Gellermann, G. P., Brodhun, M., Götz, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703793104 · Cited by 218
Abulrob, A., Sprong, H., En Henegouwen, P. V. B., & Stanimirovic, D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03463.x · Cited by 216
Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs)
Maass, D. R., Sepulveda, J., Pernthaner, A., & Shoemaker, C. B. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.04.008 · Cited by 214
SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression
Huang, L., Gainkam, L. O. T., Caveliers, V., Vanhove, C., Keyaerts, M., De Baetselier, P., Bossuyt, A., Revets, H., & Lahoutte, T. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0133-8 · Cited by 192
Fully human antibodies from transgenic mouse and phage display platforms
Lonberg, N. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.004 · Cited by 188
Immunomodulation of enzyme function in plants by single-domain antibody fragments
Jobling, S. A., Jarman, C., Teh, M.-M., Holmberg, N., Blake, C., & Verhoeyen, M. E. (2003) · Nature Biotechnology · doi:10.1038/nbt772 · Cited by 186
Goldman, E. R., Anderson, G. P., Liu, J. L., Delehanty, J. B., Sherwood, L. J., Osborn, L. E., Cummins, L. B., & Hayhurst, A. (2006) · Analytical Chemistry · doi:10.1021/ac0610053 · Cited by 183
Korotkov, K. V., Pardon, E., Steyaert, J., & Hol, W. G. J. (2009) · Structure · doi:10.1016/j.str.2008.11.011 · Cited by 181
Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
Baral, T. N., Magez, S., Stijlemans, B., Conrath, K., Vanhollebeke, B., Pays, E., Muyldermans, S., & De Baetselier, P. (2006) · Nature Medicine · doi:10.1038/nm1395 · Cited by 166
Camelid Heavy-Chain Variable Domains Provide Efficient Combining Sites to Haptens
Spinelli, S., Frenken, L. G. J., Hermans, P., Verrips, T., Brown, K., Tegoni, M., & Cambillau, C. (2000) · Biochemistry · doi:10.1021/bi991830w · Cited by 163
Adriouch, S., Hubert, S., Pechberty, S., Koch‐Nolte, F., Haag, F., & Séman, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.186 · Cited by 162
Self-citationBraden, B. C., Souchon, H., Eiselé, J.-L., Bentley, G. A., Bhat, T. N., Navaza, J., & Poljak, R. J. (1994) · Journal of Molecular Biology · doi:10.1016/0022-2836(94)90046-9 · Cited by 160
Pant, N., Hultberg, A., Zhao, Y., Svensson, L., Pan‐Hammarström, Q., Johansen, K., Pouwels, P. H., Ruggeri, F. M., Hermans, P., Frenken, L. G. J., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/508747 · Cited by 158
Hulstein, J. J. J., de Groot, P. G., Silence, K., Veyradier, A., Fijnheer, R., & Lenting, P. J. (2005) · Blood · doi:10.1182/blood-2005-03-1153 · Cited by 151
Saerens, D., Kinne, J., Bosmans, E., Wernery, U., Muyldermans, S., & Conrath, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409292200 · Cited by 148
Scheuplein, F., Schwarz, N., Adriouch, S., Krebs, C. F., Bannas, P., Rissiek, B., Séman, M., Haag, F., & Koch‐Nolte, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801711 · Cited by 147
Self-citationHmila, I., Abderrazek, R. B., Saerens, D., Benlasfar, Z., Conrath, K., Ayeb, M. E., Muyldermans, S., & Bouhaouala‐Zahar, B. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.04.011 · Cited by 144
Isolation of Llama Antibody Fragments for Prevention of Dandruff by Phage Display in Shampoo
Dolk, E., van der Vaart, M., Hulsik, D. L., Vriend, G., de Haard, H., Spinelli, S., Cambillau, C., Frenken, L. G. J., & Verrips, T. C. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.1.442-450.2005 · Cited by 144
Ladenson, R. C., Crimmins, D. L., Landt, Y., & Ladenson, J. H. (2006) · Analytical Chemistry · doi:10.1021/ac058044j · Cited by 142
Quigley, A. F., Beirnaert, E., Aasa-Chapman, M. M. I., Hoorelbeke, B., Hijazi, K., Koh, W., Tack, V., Szynol, A., Kelly, C. G., McKnight, Á., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01379-08 · Cited by 140
Lafaye, P. J., Achour, I., England, P., Duyckaerts, C. J., & Rougeon, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.008 · Cited by 131
Adriouch, S., Bannas, P., Schwarz, N., Fliegert, R., Guse, A. H., Séman, M., Haag, F., & Koch‐Nolte, F. (2007) · The FASEB Journal · doi:10.1096/fj.07-9294com · Cited by 131
Self-citationGura, T. (2002) · Nature · doi:10.1038/417584a · Cited by 131
Spinelli, S., Desmyter, A., Verrips, C. T., de Haard, H., Moineau, S., & Cambillau, C. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1029 · Cited by 130
Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library
Liu, J. L., Anderson, G. P., Delehanty, J. B., Baumann, R. G., Hayhurst, A., & Goldman, E. R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.07.299 · Cited by 126
Saerens, D., Frederix, F., Reekmans, G., Conrath, K., Jans, K., Brys, L., Huang, L., Bosmans, E., Maes, G., Borghs, G., et al. (2005) · Analytical Chemistry · doi:10.1021/ac051092j · Cited by 125
Garaicoechea, L., Olichon, A., Marcoppido, G. A., Wigdorovitz, A., Mozgovoj, M., Saif, L. J., Surrey, T., & Parreño, V. G. (2008) · Journal of Virology · doi:10.1128/jvi.00436-08 · Cited by 125
Harmsen, M. M., van Solt, C. B., Bemmel, A. M. V. Z.-V., Niewold, T., & van Zijderveld, F. G. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0300-7 · Cited by 125
Koch‐Nolte, F., Reyelt, J., Schößow, B., Schwarz, N., Scheuplein, F., Rothenburg, S., Haag, F., Alzogaray, V., Cauerhff, A., & Goldbaum, F. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8661com · Cited by 123
Self-citationHenderson, K. A., Streltsov, V. A., Coley, A. M., Dolezal, O., Hudson, P. J., Batchelor, A. H., Gupta, A., Bai, T., Murphy, V. J., Anders, R. F., et al. (2007) · Structure · doi:10.1016/j.str.2007.09.011 · Cited by 118
(2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-05971-5 · Cited by 117
Vandervaart, J. P., Pant, N., Wolvers, D. A. W., Bezemer, S., Hermans, P., Bellamy, K., Sarker, S. A., VANDERLOGT, C., Svensson, L., & Verrips, C. T. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.045 · Cited by 112
Generation of llama single-domain antibodies against methotrexate, a prototypical hapten
Alvarez-Rueda, N., Béhar, G., Ferré, V., Pugnière, M., Roquet, F., Gastinel, L. N., Jacquot, C., Aubry, J., Baty, D., Barbet, J., et al. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.08.007 · Cited by 100
Béhar, G., Sibéril, S., Groulet, A., Chames, P., Pugnière, M., Boix, C., Sautès‐Fridman, C., Teillaud, J., & Baty, D. (2007) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm064 · Cited by 99
Phage Display of Antibody Fragments
Pini, A., & Bracci, L. (2000) · Current Protein and Peptide Science · doi:10.2174/1389203003381397 · Cited by 97
Verheesen, P., de Kluijver, A., van Koningsbruggen, S., de Brij, M., de Haard, H., van Ommen, G. B., van der Maarel, S. M., & Verrips, C. T. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi432 · Cited by 94
Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris
Rahbarizadeh, F., Rasaee, M. J., Forouzandeh, M., & Allameh, A. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.03.003 · Cited by 93
Lam, A. Y., Pardon, E., Korotkov, K. V., Hol, W. G. J., & Steyaert, J. (2008) · Journal of Structural Biology · doi:10.1016/j.jsb.2008.11.008 · Cited by 89
Generation of heavy-chain-only antibodies in mice
Janssens, R., Dekker, S., Hendriks, R. W., Panayotou, G., van Remoortere, A., San, J. K. A., Grosveld, F. G., & Drabek, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601108103 · Cited by 89
Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis
Deckers, N., Saerens, D., Kanobana, K., Conrath, K., Victor, B., Wernery, U., Vercruysse, J., Muyldermans, S., & Dorny, P. (2008) · International Journal for Parasitology · doi:10.1016/j.ijpara.2008.10.012 · Cited by 86
Harmsen, M. M., van Solt, C. B., Fijten, H., van Keulen, L. J. M., Rosalia, R. A., Weerdmeester, K., Cornelissen, A. H. M., de Bruin, M. G. M., Eblé, P. L., & Dekker, A. (2006) · Veterinary Microbiology · doi:10.1016/j.vetmic.2006.10.029 · Cited by 85
Olichon, A., & Surrey, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704908200 · Cited by 84
Laune, D., Molina, F., Ferrières, G., Mani, J. C., Cohen, P. A., Simon, D., Bernardi, T., Biard‐Piechaczyk, M., Pau, B., & Granier, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30937 · Cited by 80
Doyle, P. J., Arbabi‐Ghahroudi, M., Gaudette, N., Furzer, G., Savard, M. E., Gleddie, S., McLean, M. D., MacKenzie, C. R., & Hall, J. C. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.005 · Cited by 80
de Haard, H., Bezemer, S., Ledeboer, A. M., Müller, W. H., Boender, P. J., Moineau, S., Coppelmans, M.-C., Verkleij, A. J., Frenken, L. G. J., & Verrips, C. T. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.13.4531-4541.2005 · Cited by 77
Chan, P., Pardon, E., Menzer, L., Genst, E. D., Kumita, J. R., Christodoulou, J., Saerens, D., Brans, A., Bouillenne, F., Archer, D. B., et al. (2008) · Biochemistry · doi:10.1021/bi8005797 · Cited by 72
Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides
Laplagne, D. A., Zylberman, V., Ainciart, N., Steward, M. W., Sciutto, E., Fossati, C. A., & Goldbaum, F. A. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20248 · Cited by 70
Self-citationParallel selection of multiple anti-infectome Nanobodies without access to purified antigens
Saerens, D., Stijlemans, B., Baral, T. N., Thi, G. T. N., Wernery, U., Magez, S., BAETSELIER, P. D., Muyldermans, S., & Conrath, K. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.10.005 · Cited by 69
Liu, J. L., Anderson, G. P., & Goldman, E. R. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-78 · Cited by 67
Harmsen, M. M., van Solt, C. B., Hoogendoorn, A., van Zijderveld, F., Niewold, T., & van der Meulen, J. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.09.005 · Cited by 64
Improved anti-IgG and HSA affinity ligands: Clinical application of VHH antibody technology
Klooster, R., Maassen, B., Stam, J. C., Hermans, P., ten Haaft, M. R., Detmers, F. J. M., de Haard, H., Post, J. A., & Verrips, C. T. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.04.005 · Cited by 63
Meddeb‐Mouelhi, F., Bouhaouala‐Zahar, B., Benlasfar, Z., Hammadi, M., Mejri, T., Moslah, M., Karoui, H., Khorchani, T., & Ayeb, M. E. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.10.021 · Cited by 60
Chartier, A., Raz, V., Sterrenburg, E., Verrips, C. T., van der Maarel, S. M., & Simonelig, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp101 · Cited by 60
Harrison, R. A., Hasson, S. S., Harmsen, M. M., Laing, G. D., Conrath, K., & Theakston, R. D. G. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.10.017 · Cited by 59
Stewart, C., MacKenzie, C. R., & Hall, J. C. (2006) · Toxicon · doi:10.1016/j.toxicon.2006.11.023 · Cited by 58
Llama‐derived single‐domain intrabodies inhibit secretion of hepatitis B virions in mice†
Serruys, B., Houtte, F. V., Verbrugghe, P., Leroux-Roels, G. G., & Vanlandschoot, P. (2008) · Hepatology · doi:10.1002/hep.22609 · Cited by 58
Ledeboer, A. M., Bezemer, S., de Haard, J. J. W., Schäffers, I. M., Verrips, C. T., van Vliet, C., Düsterhöft, E., Zoon, P., Moineau, S., & Frenken, L. G. J. (2002) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(02)74204-5 · Cited by 55
Gueorguieva, D., Li, S., Walsh, N., Mukerji, A., Tanha, J., & Pandey, S. (2006) · The FASEB Journal · doi:10.1096/fj.06-6306fje · Cited by 53
Thermostable Llama Single Domain Antibodies for Detection of Botulinum A Neurotoxin Complex
Goldman, E. R., Anderson, G. P., Conway, J. O., Sherwood, L. J., Fech, M., Vo, B. T., Liu, J. L., & Hayhurst, A. (2008) · Analytical Chemistry · doi:10.1021/ac8014774 · Cited by 51
TNT detection using llama antibodies and a two-step competitive fluid array immunoassay
Anderson, G. P., & Goldman, E. R. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.08.001 · Cited by 48
Dekker, S., Toussaint, W., Panayotou, G., de Wit, T., Visser, P., Grosveld, F. G., & Drabek, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.22.12132-12139.2003 · Cited by 45
Groot, A. J., Verheesen, P., Westerlaken, E. J., Gort, E. H., van der Groep, P., Bovenschen, N., van der Wall, E., van Diest, P. J., & Shvarts, A. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700395 · Cited by 44
Ecto-ADP-ribose Transferases: Cell-Surface Response to Local Tissue Injury
Żółkiewska, A. (2005) · Physiology · doi:10.1152/physiol.00028.2005 · Cited by 43
Koch‐Nolte, F., Adriouch, S., Bannas, P., Krebs, C. F., Scheuplein, F., Séman, M., & Haag, F. (2006) · Annals of Medicine · doi:10.1080/07853890600655499 · Cited by 42
Self-citationKrüger, C., Hultberg, A., Marcotte, H., Hermans, P., Bezemer, S., Frenken, L. G. J., & Hammarström, L. L. G. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0347-0 · Cited by 37
van Koningsbruggen, S., de Haard, H., de Kievit, P., Dirks, R. W., van Remoortere, A., Groot, A. J., van Engelen, B. G. M., den Dunnen, J. T., Verrips, C. T., Frants, R. R., et al. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00232-1 · Cited by 36
Khattabi, M. E., Adams, H., Heezius, E. C. J. M., Hermans, P., Detmers, F. J. M., Maassen, B., van der Ley, P., Tommassen, J., Verrips, T. C., & Stam, J. C. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00107-06 · Cited by 35
Expression of a Dromedary Heavy Chain-Only Antibody and B Cell Development in the Mouse
Zou, X., Smith, J. A., Nguyen, V. K., Ren, L., Luyten, K., Muyldermans, S., & Brüggemann, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3769 · Cited by 32
Ablynx Makes Nanobodies from Llama Bodies
Wolfson, W. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.12.003 · Cited by 32
Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures
Simmons, D. P., Streltsov, V. A., Dolezal, O., Hudson, P. J., Coley, A. M., Foley, M., Proll, D. F., & Nuttall, S. D. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21663 · Cited by 32
Harmsen, M. M., Fijten, H., Dekker, A., & Eblé, P. L. (2008) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.04.030 · Cited by 32
Conditional Inactivation of HIF-1 Using Intrabodies
Groot, A. J., Gort, E. H., van der Wall, E., van Diest, P. J., & Vooijs, M. (2008) · Analytical Cellular Pathology · doi:10.1155/2008/384945 · Cited by 29
Ratier, L., Urrutia, M., Paris, G., Zarebski, L. M., Frasch, A. C. C., & Goldbaum, F. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003524 · Cited by 28
Self-citationHead‐to‐tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid
Winichayakul, S., Pernthaner, A., Scott, R., Vlaming, R., & Roberts, N. (2008) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20080076 · Cited by 24
Production and Characterization of a High-Affinity Nanobody Against Human Endoglin
Ahmadvand, D., Rasaee, M. J., Rahbarizadeh, F., & Mohammadi, M. (2008) · Hybridoma · doi:10.1089/hyb.2008.0014 · Cited by 20
The unique properties of camelid IgG have potential to improve the treatment of snake bite
Harrison, R. A., & Wernery, U. (2007) · Cited by 10
Cited by
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304
PEGylation of therapeutic proteins
Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681
Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics
Bannas, P., Hambach, J., & Koch-Nolte, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01603 · Cited by 572
Epidermal growth factor receptor targeting in cancer: a review of trends and strategies
Yewale, C., Baradia, D., Vhora, I., Patil, S., & Misra, A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.100 · Cited by 533
Emerging new therapeutic antibody derivatives for cancer treatment
Jin, S., Sun, Y., Liang, X., Gu, X., Ning, J., Xu, Y., Chen, S., & Pan, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00868-x · Cited by 459
Metadata
- Authors
- Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., Cauerhff, A., Danquah, W., Rissiek, B., Scheuplein, F., Schwarz, N., Adriouch, S., Boyer, O., Seman, M., Licea, A., Serreze, D. V., Goldbaum, F. A., Haag, F., & Koch-Nolte, F.
- Venue
- Medical Microbiology and Immunology
- Published
- 2009-06-16
- Volume
- 198
- Issue
- 3
- Pages
- 157-174
- ISSN
- 0044-3077 (ISSN-L)
- 0300-8584
- 1432-1831
- OpenAlex
- W2120929471
- Cited by
- 513
- References
- 112
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.